Rafael Amado - Insider Trading & Ownership
-
Entity
-
Individual
-
Location
-
210 East Grand Ave, South San Francisco, CA
-
Summary
-
The estimated net worth of Rafael Amado is at least $2.56M dollars as of August 14, 2024. Rafael Amado is the EVP of R&D of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $1.72M. Rafael Amado is the President, Head of Global Oncology Research and Development of Zai Lab Ltd and owns shares of Zai Lab Ltd (ZLAB) stock worth about $592K. Rafael Amado is the Director of Poseida Therapeutics, Inc. and owns shares of Poseida Therapeutics, Inc. (PSTX) stock worth about $243K.